The ten "hard" questions in pediatric functional constipation

Flora Fedele1, Maria Teresa Fioretti1, Elena Scarpato1

  • 1Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

PubMed

Insights

Chronic functional constipation affects many children, impacting their well-being. This review offers pediatric gastroenterologists a guide for managing childhood constipation using non-pharmacological and pharmacological treatments, primarily polyethylene glycol (PEG).

Area of Science:

  • Pediatric Gastroenterology
  • Childhood Functional Gastrointestinal Disorders

Background:

  • Functional constipation is prevalent in children, significantly impacting their quality of life.
  • Approximately 95% of childhood constipation cases lack an organic cause, defining chronic functional constipation.
  • Diagnosis relies on the Rome criteria and is primarily clinical, avoiding routine investigations unless alarm symptoms are present.

Purpose of the Study:

  • To provide pediatric gastroenterologists with a practical guide for managing chronic functional constipation in children and adolescents.
  • To outline current evidence-based non-pharmacological and pharmacological treatment strategies.
  • To emphasize the role of polyethylene glycol (PEG) as a first-line therapy.

Main Methods:

  • This is a review article, synthesizing existing literature and clinical guidelines.
  • It focuses on diagnostic criteria, non-pharmacological interventions, and pharmacological management.
  • Key therapeutic agents, particularly osmotic laxatives like PEG, are discussed.

Main Results:

  • Non-pharmacological approaches include education, demystification, and toilet training.
  • Pharmacological management involves disimpaction, maintenance therapy, and medication weaning.
  • Polyethylene glycol (PEG) is the recommended first-choice laxative for both disimpaction and maintenance.

Conclusions:

  • Effective management of childhood functional constipation requires a comprehensive approach combining behavioral and pharmacological strategies.
  • Pediatric gastroenterologists can utilize this review as a tool for optimizing patient care.
  • Early and appropriate intervention, guided by established criteria and treatments like PEG, is crucial for improving outcomes.

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
205
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
202
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
346
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
157
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
83